| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glutamate receptor binding | 1.09e-06 | 81 | 83 | 6 | GO:0035254 | |
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 4.53e-06 | 27 | 83 | 4 | GO:0004683 | |
| GeneOntologyMolecularFunction | actin binding | MYO10 CAMK2B PHACTR4 DBNL TRIOBP PPP1R9B LASP1 LMOD2 MPRIP PHACTR1 | 2.92e-05 | 479 | 83 | 10 | GO:0003779 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | MST1R CAMK2A CAMK2B CAMK2D SPEG CAMK2G PPP1R9B PFKFB4 FGR MAP3K21 FYN MAST3 | 3.52e-05 | 709 | 83 | 12 | GO:0016773 |
| GeneOntologyMolecularFunction | protein kinase activity | MST1R CAMK2A CAMK2B CAMK2D SPEG CAMK2G PPP1R9B FGR MAP3K21 FYN MAST3 | 3.74e-05 | 600 | 83 | 11 | GO:0004672 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TUBGCP6 MYO10 CAMK2B CAMK2D PHACTR4 DBNL TRIOBP PPP1R9B HOOK2 LASP1 GNAS FYN LMOD2 MPRIP PHACTR1 | 4.19e-05 | 1099 | 83 | 15 | GO:0008092 |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 6.45e-05 | 52 | 83 | 4 | GO:0035255 | |
| GeneOntologyMolecularFunction | kinase activity | MST1R CAMK2A CAMK2B CAMK2D SPEG CAMK2G PPP1R9B PFKFB4 FGR MAP3K21 FYN MAST3 | 7.22e-05 | 764 | 83 | 12 | GO:0016301 |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 3.15e-04 | 32 | 83 | 3 | GO:0099186 | |
| GeneOntologyMolecularFunction | actin filament binding | 3.68e-04 | 227 | 83 | 6 | GO:0051015 | |
| GeneOntologyMolecularFunction | calmodulin binding | 3.94e-04 | 230 | 83 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | protein phosphatase 1 binding | 4.12e-04 | 35 | 83 | 3 | GO:0008157 | |
| GeneOntologyMolecularFunction | interleukin-1 receptor activity | 4.70e-04 | 8 | 83 | 2 | GO:0004908 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | MST1R CAMK2A CAMK2B CAMK2D SPEG CAMK2G PPP1R9B PFKFB4 FGR MAP3K21 FYN MAST3 | 4.81e-04 | 938 | 83 | 12 | GO:0016772 |
| GeneOntologyMolecularFunction | structural constituent of synapse | 7.07e-04 | 42 | 83 | 3 | GO:0098918 | |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine kinase activity | 7.52e-04 | 10 | 83 | 2 | GO:0009931 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 7.87e-04 | 363 | 83 | 7 | GO:0106310 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 9.16e-04 | 11 | 83 | 2 | GO:0098973 | |
| GeneOntologyMolecularFunction | NAD+ nucleosidase activity | 1.10e-03 | 12 | 83 | 2 | GO:0003953 | |
| GeneOntologyMolecularFunction | protein phosphatase inhibitor activity | 1.18e-03 | 50 | 83 | 3 | GO:0004864 | |
| GeneOntologyMolecularFunction | phosphatase inhibitor activity | 1.47e-03 | 54 | 83 | 3 | GO:0019212 | |
| GeneOntologyMolecularFunction | NAD+ nucleotidase, cyclic ADP-ribose generating | 1.97e-03 | 16 | 83 | 2 | GO:0061809 | |
| GeneOntologyMolecularFunction | peptide binding | 2.10e-03 | 318 | 83 | 6 | GO:0042277 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 2.55e-03 | 446 | 83 | 7 | GO:0004674 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | TGFB2 WASHC4 CAMK2D DBNL LRP1 TRIOBP FGR ARFIP2 ARFIP1 TACSTD2 LMOD2 | 1.43e-06 | 438 | 83 | 11 | GO:0032970 |
| GeneOntologyBiologicalProcess | actin filament-based process | TGFB2 ELMO3 WASHC4 CAMK2D PHACTR4 DBNL LRP1 TRIOBP PPP1R9B FGR ARFIP2 ARFIP1 TACSTD2 LMOD2 PHACTR1 | 3.14e-06 | 912 | 83 | 15 | GO:0030029 |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | TGFB2 WASHC4 DBNL LRP1 TRIOBP FGR ARFIP2 ARFIP1 TACSTD2 LMOD2 | 3.23e-06 | 384 | 83 | 10 | GO:0032956 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | TGFB2 ELMO3 WASHC4 PHACTR4 DBNL LRP1 TRIOBP PPP1R9B FGR ARFIP2 ARFIP1 TACSTD2 LMOD2 PHACTR1 | 3.58e-06 | 803 | 83 | 14 | GO:0030036 |
| GeneOntologyBiologicalProcess | neurotransmitter receptor internalization | 3.62e-06 | 58 | 83 | 5 | GO:0099590 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to membrane | 5.07e-06 | 237 | 83 | 8 | GO:1905475 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell periphery | 5.82e-06 | 171 | 83 | 7 | GO:1904375 | |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNG3 CACNG2 TGFB2 TRPC7 CAMK2A CAMK2B CAMK2D CAMK2G ANXA6 FYN PML | 6.03e-06 | 509 | 83 | 11 | GO:0006816 |
| GeneOntologyBiologicalProcess | regulation of protein localization to plasma membrane | 1.30e-05 | 128 | 83 | 6 | GO:1903076 | |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 1.62e-05 | 278 | 83 | 8 | GO:0031503 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor diffusion trapping | 1.75e-05 | 13 | 83 | 3 | GO:0099628 | |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor diffusion trapping | 1.75e-05 | 13 | 83 | 3 | GO:0098970 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | TGFB2 INTU WASHC4 CAMK2B DBNL USP7 LRP1 TRIOBP FGR ARFIP2 IL1RAP ARFIP1 TACSTD2 LMOD2 PGAM5 STN1 PML | 2.04e-05 | 1342 | 83 | 17 | GO:0033043 |
| GeneOntologyBiologicalProcess | receptor diffusion trapping | 2.22e-05 | 14 | 83 | 3 | GO:0098953 | |
| GeneOntologyBiologicalProcess | cell junction organization | CACNG2 TGFB2 THBS1 SHANK2 PCDHGC4 CAMK2B DBNL LRP1 ADGRL1 PPP1R9B PATJ IL1RAP FYN SVEP1 | 3.15e-05 | 974 | 83 | 14 | GO:0034330 |
| GeneOntologyBiologicalProcess | actin filament organization | ELMO3 WASHC4 DBNL TRIOBP PPP1R9B ARFIP2 ARFIP1 TACSTD2 LMOD2 PHACTR1 | 3.72e-05 | 509 | 83 | 10 | GO:0007015 |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 3.74e-05 | 228 | 83 | 7 | GO:0046777 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNG3 CACNG2 TGFB2 TRPC7 CAMK2A CAMK2B CAMK2D CAMK2G ANXA6 KCNS2 GNAS KCNG3 FYN PML | 4.20e-05 | 1000 | 83 | 14 | GO:0030001 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane neurotransmitter receptor levels | 5.25e-05 | 164 | 83 | 6 | GO:0099072 | |
| GeneOntologyBiologicalProcess | regulation of cellular localization | CACNG2 TGFB2 PDE4C CAMK2A CAMK2B CAMK2D CAMK2G USP7 LRP1 PPP1R9B GNAS ARFIP1 FYN KDM1A PML | 8.81e-05 | 1212 | 83 | 15 | GO:0060341 |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 1.02e-04 | 185 | 83 | 6 | GO:0099175 | |
| GeneOntologyBiologicalProcess | regulation of protein localization | CACNG2 TGFB2 PDE4C CAMK2A CAMK2B CAMK2D CAMK2G LRP1 PPP1R9B GNAS ARFIP1 FYN KDM1A PML | 1.03e-04 | 1087 | 83 | 14 | GO:0032880 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | TGFB2 WASHC4 DBNL LRP1 TRIOBP FGR ARFIP2 ARFIP1 TACSTD2 LMOD2 | 1.09e-04 | 579 | 83 | 10 | GO:0051493 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | TGFB2 TUBGCP6 ELMO3 WASHC4 DBNL TRIOBP PPP1R9B HOOK2 ARFIP2 ARFIP1 TACSTD2 LMOD2 PHACTR1 | 1.10e-04 | 957 | 83 | 13 | GO:0097435 |
| GeneOntologyBiologicalProcess | endocytosis | CACNG3 CACNG2 MST1R THBS1 ELMO3 DBNL LRP1 SH3GLB2 RNF216 HOOK2 FGR FYN | 1.13e-04 | 827 | 83 | 12 | GO:0006897 |
| GeneOntologyBiologicalProcess | regulation of neuron migration | 1.14e-04 | 62 | 83 | 4 | GO:2001222 | |
| GeneOntologyBiologicalProcess | actin nucleation | 1.37e-04 | 65 | 83 | 4 | GO:0045010 | |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 1.45e-04 | 66 | 83 | 4 | GO:0030042 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 1.48e-04 | 198 | 83 | 6 | GO:0048813 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 1.62e-04 | 493 | 83 | 9 | GO:0010959 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNG3 CACNG2 TGFB2 TRPC7 CAMK2A CAMK2B CAMK2D CAMK2G ANXA6 KCNS2 GNAS KCNG3 FYN PML | 1.97e-04 | 1157 | 83 | 14 | GO:0006812 |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | 2.07e-04 | 300 | 83 | 7 | GO:0110053 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate adhesion | 2.26e-04 | 74 | 83 | 4 | GO:0010812 | |
| GeneOntologyBiologicalProcess | regulation of Arp2/3 complex-mediated actin nucleation | 2.60e-04 | 31 | 83 | 3 | GO:0034315 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | 2.97e-04 | 422 | 83 | 8 | GO:1990778 | |
| GeneOntologyBiologicalProcess | response to immobilization stress | 3.14e-04 | 33 | 83 | 3 | GO:0035902 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | TGFB2 PCSK5 THBS1 MYO10 HLA-DQB1 NEXMIF LRP1 TRIOBP TACSTD2 FYN IL1RL2 PML | 3.23e-04 | 927 | 83 | 12 | GO:0030155 |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 3.25e-04 | 323 | 83 | 7 | GO:0051924 | |
| GeneOntologyBiologicalProcess | regulation of retrograde transport, endosome to Golgi | 3.32e-04 | 7 | 83 | 2 | GO:1905279 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNG3 CACNG2 TGFB2 TRPC7 CAMK2A CAMK2B CAMK2D CAMK2G ANXA6 KCNS2 LASP1 GNAS KCNG3 FYN PML | 3.47e-04 | 1374 | 83 | 15 | GO:0006811 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | TGFB2 THBS1 DSC3 PCDHGC4 MYO10 HLA-DQB1 NEXMIF ADGRL1 GNAS IL1RAP FYN IL1RL2 SVEP1 | 3.51e-04 | 1077 | 83 | 13 | GO:0098609 |
| GeneOntologyBiologicalProcess | dendrite development | 4.04e-04 | 335 | 83 | 7 | GO:0016358 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport, postsynaptic endosome to lysosome | 4.41e-04 | 8 | 83 | 2 | GO:0098943 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 5.15e-04 | 577 | 83 | 9 | GO:0043269 | |
| GeneOntologyBiologicalProcess | protein localization to membrane | CACNG3 CACNG2 CAMK2A CAMK2B CAMK2D CAMK2G LRP1 PPP1R9B FYN NACAD | 5.24e-04 | 705 | 83 | 10 | GO:0072657 |
| GeneOntologyBiologicalProcess | hair follicle morphogenesis | 5.58e-04 | 40 | 83 | 3 | GO:0031069 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 5.62e-04 | 254 | 83 | 6 | GO:0010810 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | CERS2 INTU MYO10 CAMK2B CAMK2G DBNL LRP1 TACSTD2 FYN CUX1 KDM1A | 5.64e-04 | 846 | 83 | 11 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of relaxation of cardiac muscle | 5.65e-04 | 9 | 83 | 2 | GO:1901897 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transport | 5.96e-04 | 589 | 83 | 9 | GO:0034762 | |
| GeneOntologyBiologicalProcess | regulation of actin nucleation | 6.00e-04 | 41 | 83 | 3 | GO:0051125 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport | 6.44e-04 | 42 | 83 | 3 | GO:0099637 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | CERS2 INTU MYO10 CAMK2B CAMK2G DBNL LRP1 TACSTD2 FYN CUX1 KDM1A | 6.65e-04 | 863 | 83 | 11 | GO:0031344 |
| GeneOntologyBiologicalProcess | negative regulation of cell-matrix adhesion | 6.90e-04 | 43 | 83 | 3 | GO:0001953 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, glutamatergic | 6.90e-04 | 43 | 83 | 3 | GO:0051968 | |
| GeneOntologyBiologicalProcess | positive regulation of synapse maturation | 7.05e-04 | 10 | 83 | 2 | GO:0090129 | |
| GeneOntologyBiologicalProcess | positive regulation of smoothened signaling pathway | 7.89e-04 | 45 | 83 | 3 | GO:0045880 | |
| GeneOntologyBiologicalProcess | phagocytosis | 8.35e-04 | 274 | 83 | 6 | GO:0006909 | |
| GeneOntologyBiologicalProcess | actin filament capping | 8.42e-04 | 46 | 83 | 3 | GO:0051693 | |
| GeneOntologyBiologicalProcess | epidermis morphogenesis | 8.42e-04 | 46 | 83 | 3 | GO:0048730 | |
| GeneOntologyBiologicalProcess | receptor internalization | 8.43e-04 | 182 | 83 | 5 | GO:0031623 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | 8.61e-04 | 752 | 83 | 10 | GO:1901699 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 8.83e-04 | 277 | 83 | 6 | GO:0048705 | |
| GeneOntologyBiologicalProcess | Arp2/3 complex-mediated actin nucleation | 8.97e-04 | 47 | 83 | 3 | GO:0034314 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 9.07e-04 | 185 | 83 | 5 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 9.07e-04 | 185 | 83 | 5 | GO:0035108 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 9.47e-04 | 387 | 83 | 7 | GO:0050807 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor localization to postsynaptic specialization membrane | 1.01e-03 | 49 | 83 | 3 | GO:0099645 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic specialization membrane | 1.01e-03 | 49 | 83 | 3 | GO:0099633 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 1.02e-03 | 392 | 83 | 7 | GO:0070588 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | TGFB2 CERS2 PCSK5 THBS1 FBN2 CAMK2A CAMK2B NEXMIF CAMK2D LRP1 FGR TACSTD2 PHACTR1 | 1.05e-03 | 1211 | 83 | 13 | GO:0030334 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 1.07e-03 | 395 | 83 | 7 | GO:0050803 | |
| GeneOntologyBiologicalProcess | postsynaptic endocytosis | 1.14e-03 | 51 | 83 | 3 | GO:0140239 | |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor internalization | 1.14e-03 | 51 | 83 | 3 | GO:0098884 | |
| GeneOntologyBiologicalProcess | import into cell | CACNG3 CACNG2 MST1R THBS1 ELMO3 DBNL LRP1 SH3GLB2 RNF216 HOOK2 FGR FYN | 1.18e-03 | 1074 | 83 | 12 | GO:0098657 |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 1.20e-03 | 52 | 83 | 3 | GO:0030835 | |
| GeneOntologyBiologicalProcess | regulation of Schwann cell migration | 1.21e-03 | 13 | 83 | 2 | GO:1900147 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.32e-03 | 410 | 83 | 7 | GO:0031589 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | CACNG3 CACNG2 SHANK2 SV2A CAMK2A CAMK2B APBA1 RNF216 IL1RAP FYN CRHBP | 1.32e-03 | 939 | 83 | 11 | GO:0099537 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | TGFB2 THBS1 MYO10 CAMK2B DBNL LRP1 FGR TACSTD2 FYN PGAM5 CUX1 PML | 1.34e-03 | 1090 | 83 | 12 | GO:0022603 |
| GeneOntologyBiologicalProcess | localization within membrane | CACNG3 CACNG2 CAMK2A CAMK2B CAMK2D CAMK2G LRP1 PPP1R9B FYN NACAD | 1.35e-03 | 798 | 83 | 10 | GO:0051668 |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | 1.38e-03 | 302 | 83 | 6 | GO:0022604 | |
| GeneOntologyBiologicalProcess | Schwann cell migration | 1.41e-03 | 14 | 83 | 2 | GO:0036135 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 1.48e-03 | 418 | 83 | 7 | GO:0051962 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor activity | 1.49e-03 | 56 | 83 | 3 | GO:0099601 | |
| GeneOntologyBiologicalProcess | hair follicle development | 1.54e-03 | 123 | 83 | 4 | GO:0001942 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in morphogenesis | 1.62e-03 | 15 | 83 | 2 | GO:1902337 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 1.65e-03 | 313 | 83 | 6 | GO:0099173 | |
| GeneOntologyBiologicalProcess | molting cycle process | 1.68e-03 | 126 | 83 | 4 | GO:0022404 | |
| GeneOntologyBiologicalProcess | hair cycle process | 1.68e-03 | 126 | 83 | 4 | GO:0022405 | |
| GeneOntologyBiologicalProcess | synapse organization | 1.71e-03 | 685 | 83 | 9 | GO:0050808 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | TGFB2 CERS2 PCSK5 THBS1 FBN2 CAMK2A CAMK2B NEXMIF CAMK2D LRP1 FGR TACSTD2 PHACTR1 | 1.73e-03 | 1280 | 83 | 13 | GO:2000145 |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 1.21e-09 | 5 | 84 | 4 | GO:0005954 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 2.21e-06 | 212 | 84 | 8 | GO:0030666 | |
| GeneOntologyCellularComponent | glutamatergic synapse | CACNG3 CACNG2 SHANK2 SV2A CAMK2A CAMK2B DBNL APBA1 LRP1 SH3GLB2 ADGRL1 RNF216 IL1RAP FYN | 4.34e-06 | 817 | 84 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | neuronal cell body | TGFB2 PCSK5 SHANK2 MYO10 SV2A CAMK2A CAMK2B CAMK2D DBNL LRP1 PPP1R9B GNAS FYN CRHBP | 5.57e-06 | 835 | 84 | 14 | GO:0043025 |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNG3 CACNG2 TGFB2 PCSK5 SHANK2 MYO10 SV2A CAMK2A CAMK2B CAMK2D DBNL APBA1 LRP1 PPP1R9B GNAS FYN CRHBP | 6.38e-06 | 1228 | 84 | 17 | GO:0036477 |
| GeneOntologyCellularComponent | postsynapse | CACNG3 CACNG2 SHANK2 CAMK2A CAMK2B CAMK2D CAMK2G DBNL APBA1 LRP1 SH3GLB2 RNF216 PPP1R9B LASP1 FYN | 1.17e-05 | 1018 | 84 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic density | CACNG3 CACNG2 SHANK2 CAMK2A CAMK2B CAMK2G DBNL LRP1 PPP1R9B FYN | 1.31e-05 | 451 | 84 | 10 | GO:0014069 |
| GeneOntologyCellularComponent | cell body | TGFB2 PCSK5 SHANK2 MYO10 SV2A CAMK2A CAMK2B CAMK2D DBNL LRP1 PPP1R9B GNAS FYN CRHBP | 1.86e-05 | 929 | 84 | 14 | GO:0044297 |
| GeneOntologyCellularComponent | actin cytoskeleton | MST1R MYO10 DBNL TRIOBP PPP1R9B LASP1 FGR FYN LMOD2 MPRIP NCOA5 | 1.90e-05 | 576 | 84 | 11 | GO:0015629 |
| GeneOntologyCellularComponent | asymmetric synapse | CACNG3 CACNG2 SHANK2 CAMK2A CAMK2B CAMK2G DBNL LRP1 PPP1R9B FYN | 2.13e-05 | 477 | 84 | 10 | GO:0032279 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 2.80e-05 | 88 | 84 | 5 | GO:0016529 | |
| GeneOntologyCellularComponent | trans-Golgi network | 3.20e-05 | 306 | 84 | 8 | GO:0005802 | |
| GeneOntologyCellularComponent | postsynaptic specialization | CACNG3 CACNG2 SHANK2 CAMK2A CAMK2B CAMK2G DBNL LRP1 PPP1R9B FYN | 3.34e-05 | 503 | 84 | 10 | GO:0099572 |
| GeneOntologyCellularComponent | dendrite | CACNG3 PCSK5 SHANK2 SV2A CAMK2A CAMK2B DBNL APBA1 LRP1 PPP1R9B GNAS FYN CRHBP | 3.61e-05 | 858 | 84 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CACNG3 PCSK5 SHANK2 SV2A CAMK2A CAMK2B DBNL APBA1 LRP1 PPP1R9B GNAS FYN CRHBP | 3.70e-05 | 860 | 84 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 3.81e-05 | 155 | 84 | 6 | GO:0098685 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | CACNG3 CACNG2 SHANK2 CAMK2A CAMK2B CAMK2G DBNL LRP1 PPP1R9B FYN | 4.63e-05 | 523 | 84 | 10 | GO:0098984 |
| GeneOntologyCellularComponent | sarcoplasm | 9.67e-05 | 114 | 84 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | endocytic vesicle | 1.56e-04 | 384 | 84 | 8 | GO:0030139 | |
| GeneOntologyCellularComponent | ruffle | 1.83e-04 | 206 | 84 | 6 | GO:0001726 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 4.08e-04 | 443 | 84 | 8 | GO:0098791 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 7.86e-04 | 45 | 84 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | postsynaptic endocytic zone | 8.57e-04 | 11 | 84 | 2 | GO:0098843 | |
| GeneOntologyCellularComponent | trans-Golgi network membrane | 1.08e-03 | 112 | 84 | 4 | GO:0032588 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 1.26e-03 | 934 | 84 | 11 | GO:0048471 | |
| GeneOntologyCellularComponent | anchoring junction | DSC3 SV2A CAMK2D ANXA6 DBNL LRP1 TRIOBP PPP1R9B LASP1 PATJ MPRIP | 1.78e-03 | 976 | 84 | 11 | GO:0070161 |
| GeneOntologyCellularComponent | perikaryon | 2.06e-03 | 223 | 84 | 5 | GO:0043204 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | CACNG3 CACNG2 WASHC4 SV2A HLA-DQB1 CAMK2A CAMK2B CAMK2D CAMK2G ANXA6 DBNL LRP1 PML | 2.07e-03 | 1307 | 84 | 13 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | CACNG3 CACNG2 WASHC4 SV2A HLA-DQB1 CAMK2A CAMK2B CAMK2D CAMK2G ANXA6 DBNL LRP1 PML | 2.33e-03 | 1325 | 84 | 13 | GO:0012506 |
| GeneOntologyCellularComponent | synaptic membrane | 2.37e-03 | 583 | 84 | 8 | GO:0097060 | |
| GeneOntologyCellularComponent | cation channel complex | 2.58e-03 | 235 | 84 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | site of polarized growth | 3.54e-03 | 253 | 84 | 5 | GO:0030427 | |
| GeneOntologyCellularComponent | cell leading edge | 3.99e-03 | 500 | 84 | 7 | GO:0031252 | |
| Domain | CaMKII_AD | 3.81e-10 | 4 | 84 | 4 | PF08332 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 3.81e-10 | 4 | 84 | 4 | IPR013543 | |
| Domain | - | 2.64e-07 | 13 | 84 | 4 | 3.10.450.50 | |
| Domain | NTF2-like_dom | 5.00e-07 | 15 | 84 | 4 | IPR032710 | |
| Domain | PROTEIN_KINASE_ATP | MST1R CAMK2A CAMK2B CAMK2D SPEG CAMK2G FGR MAP3K21 FYN MAST3 | 3.96e-05 | 459 | 84 | 10 | PS00107 |
| Domain | Protein_kinase_ATP_BS | 5.11e-05 | 379 | 84 | 9 | IPR017441 | |
| Domain | SH3 | 5.35e-05 | 216 | 84 | 7 | SM00326 | |
| Domain | SH3 | 5.35e-05 | 216 | 84 | 7 | PS50002 | |
| Domain | PDZ | 5.47e-05 | 148 | 84 | 6 | SM00228 | |
| Domain | - | 5.89e-05 | 150 | 84 | 6 | 2.30.42.10 | |
| Domain | Arfaptin_fam | 5.98e-05 | 3 | 84 | 2 | IPR030798 | |
| Domain | SH3_domain | 6.00e-05 | 220 | 84 | 7 | IPR001452 | |
| Domain | PDZ | 6.11e-05 | 151 | 84 | 6 | PS50106 | |
| Domain | PDZ | 6.34e-05 | 152 | 84 | 6 | IPR001478 | |
| Domain | Prot_kinase_dom | MST1R CAMK2A CAMK2B CAMK2D SPEG CAMK2G FGR MAP3K21 FYN MAST3 | 6.73e-05 | 489 | 84 | 10 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | MST1R CAMK2A CAMK2B CAMK2D SPEG CAMK2G FGR MAP3K21 FYN MAST3 | 7.20e-05 | 493 | 84 | 10 | PS50011 |
| Domain | SH3_1 | 9.66e-05 | 164 | 84 | 6 | PF00018 | |
| Domain | Kinase-like_dom | MST1R CAMK2A CAMK2B CAMK2D SPEG CAMK2G FGR MAP3K21 FYN MAST3 | 1.57e-04 | 542 | 84 | 10 | IPR011009 |
| Domain | AH_dom | 1.98e-04 | 5 | 84 | 2 | IPR010504 | |
| Domain | Arfaptin | 1.98e-04 | 5 | 84 | 2 | PF06456 | |
| Domain | Arfaptin | 1.98e-04 | 5 | 84 | 2 | SM01015 | |
| Domain | AH | 1.98e-04 | 5 | 84 | 2 | PS50870 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 2.63e-04 | 69 | 84 | 4 | IPR020636 | |
| Domain | IL-1_rcpt_I/II-typ | 2.96e-04 | 6 | 84 | 2 | IPR004074 | |
| Domain | - | 3.26e-04 | 30 | 84 | 3 | 1.20.1270.60 | |
| Domain | AH/BAR-dom | 3.26e-04 | 30 | 84 | 3 | IPR027267 | |
| Domain | K_chnl_volt-dep_Kv9 | 4.14e-04 | 7 | 84 | 2 | IPR003971 | |
| Domain | RPEL | 4.14e-04 | 7 | 84 | 2 | PS51073 | |
| Domain | RPEL | 4.14e-04 | 7 | 84 | 2 | PF02755 | |
| Domain | RPEL | 4.14e-04 | 7 | 84 | 2 | SM00707 | |
| Domain | RPEL_repeat | 4.14e-04 | 7 | 84 | 2 | IPR004018 | |
| Domain | SH3_9 | 4.22e-04 | 78 | 84 | 4 | PF14604 | |
| Domain | PDZ | 4.37e-04 | 141 | 84 | 5 | PF00595 | |
| Domain | VDCC_gsu | 5.50e-04 | 8 | 84 | 2 | IPR008368 | |
| Domain | EGF_CA | 6.11e-04 | 86 | 84 | 4 | PF07645 | |
| Domain | TyrKc | 6.66e-04 | 88 | 84 | 4 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 6.66e-04 | 88 | 84 | 4 | IPR020635 | |
| Domain | PGAM | 8.79e-04 | 10 | 84 | 2 | SM00855 | |
| Domain | Amino_oxidase | 8.79e-04 | 10 | 84 | 2 | IPR002937 | |
| Domain | Amino_oxidase | 8.79e-04 | 10 | 84 | 2 | PF01593 | |
| Domain | HAT | 8.79e-04 | 10 | 84 | 2 | IPR003107 | |
| Domain | HAT | 8.79e-04 | 10 | 84 | 2 | SM00386 | |
| Domain | PG_MUTASE | 8.79e-04 | 10 | 84 | 2 | PS00175 | |
| Domain | IL-1_rcpt_fam | 1.07e-03 | 11 | 84 | 2 | IPR015621 | |
| Domain | Ser/Thr_kinase_AS | 1.13e-03 | 357 | 84 | 7 | IPR008271 | |
| Domain | S_TKc | 1.17e-03 | 359 | 84 | 7 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 1.22e-03 | 362 | 84 | 7 | PS00108 | |
| Domain | His_Phos_1 | 1.28e-03 | 12 | 84 | 2 | PF00300 | |
| Domain | His_Pase_superF_clade-1 | 1.28e-03 | 12 | 84 | 2 | IPR013078 | |
| Domain | EGF_CA | 2.24e-03 | 122 | 84 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.37e-03 | 124 | 84 | 4 | IPR001881 | |
| Domain | Pkinase_Tyr | 2.74e-03 | 129 | 84 | 4 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 3.49e-03 | 138 | 84 | 4 | IPR001245 | |
| Domain | His_PPase_superfam | 3.60e-03 | 20 | 84 | 2 | IPR029033 | |
| Domain | - | 3.60e-03 | 20 | 84 | 2 | 3.40.50.1240 | |
| Domain | TIR | 3.97e-03 | 21 | 84 | 2 | SM00255 | |
| Domain | EGF | 4.17e-03 | 235 | 84 | 5 | SM00181 | |
| Domain | TIR | 4.36e-03 | 22 | 84 | 2 | PF01582 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 3.64e-09 | 29 | 66 | 6 | MM15028 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 5.61e-09 | 31 | 66 | 6 | M7223 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 9.01e-08 | 10 | 66 | 4 | M26910 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CACNG3 CACNG2 SHANK2 CAMK2A CAMK2B CAMK2D CAMK2G DBNL APBA1 KCNS2 KCNG3 IL1RAP | 3.81e-07 | 411 | 66 | 12 | M735 |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 4.23e-07 | 14 | 66 | 4 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 4.23e-07 | 14 | 66 | 4 | M47388 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 5.75e-07 | 15 | 66 | 4 | M47385 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 9.96e-07 | 17 | 66 | 4 | M47387 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 1.61e-06 | 19 | 66 | 4 | M47957 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 1.61e-06 | 19 | 66 | 4 | MM15473 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 1.82e-06 | 44 | 66 | 5 | M27934 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 2.01e-06 | 20 | 66 | 4 | M17670 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 2.47e-06 | 21 | 66 | 4 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 2.47e-06 | 21 | 66 | 4 | M27944 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 3.01e-06 | 22 | 66 | 4 | MM15104 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CACNG3 CACNG2 CAMK2A CAMK2B CAMK2D CAMK2G APBA1 KCNS2 KCNG3 IL1RAP | 3.25e-06 | 335 | 66 | 10 | MM14503 |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 3.63e-06 | 23 | 66 | 4 | MM14953 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 3.63e-06 | 23 | 66 | 4 | M47512 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 3.63e-06 | 23 | 66 | 4 | M27949 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 4.34e-06 | 24 | 66 | 4 | M47509 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 5.15e-06 | 25 | 66 | 4 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 5.15e-06 | 25 | 66 | 4 | M47511 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 6.28e-06 | 98 | 66 | 6 | M965 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 8.24e-06 | 28 | 66 | 4 | M837 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 8.24e-06 | 28 | 66 | 4 | M47508 | |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 1.28e-05 | 65 | 66 | 5 | M38994 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 1.42e-05 | 313 | 66 | 9 | M27867 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.43e-05 | 32 | 66 | 4 | M27455 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 1.43e-05 | 32 | 66 | 4 | M27900 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 1.62e-05 | 33 | 66 | 4 | M39875 | |
| Pathway | REACTOME_RAF_ACTIVATION | 1.83e-05 | 34 | 66 | 4 | M27556 | |
| Pathway | REACTOME_RAF_ACTIVATION | 2.06e-05 | 35 | 66 | 4 | MM15271 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.06e-05 | 35 | 66 | 4 | MM15109 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 2.58e-05 | 37 | 66 | 4 | M749 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 2.87e-05 | 38 | 66 | 4 | M27255 | |
| Pathway | PID_IFNG_PATHWAY | 3.53e-05 | 40 | 66 | 4 | M161 | |
| Pathway | PID_AMB2_NEUTROPHILS_PATHWAY | 3.90e-05 | 41 | 66 | 4 | M159 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 3.90e-05 | 41 | 66 | 4 | M512 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 3.98e-05 | 82 | 66 | 5 | M27626 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 4.68e-05 | 205 | 66 | 7 | M752 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 5.17e-05 | 44 | 66 | 4 | M39845 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 5.61e-05 | 211 | 66 | 7 | MM14502 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 5.62e-05 | 144 | 66 | 6 | MM14501 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 5.65e-05 | 45 | 66 | 4 | M27623 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 6.24e-05 | 90 | 66 | 5 | M6467 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 6.30e-05 | 147 | 66 | 6 | MM15854 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 6.72e-05 | 47 | 66 | 4 | M39531 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 7.32e-05 | 151 | 66 | 6 | M39329 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 7.68e-05 | 94 | 66 | 5 | M2843 | |
| Pathway | KEGG_MELANOGENESIS | 1.08e-04 | 101 | 66 | 5 | M7761 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 1.08e-04 | 101 | 66 | 5 | M1979 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.16e-04 | 54 | 66 | 4 | M26911 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.16e-04 | 54 | 66 | 4 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.16e-04 | 54 | 66 | 4 | MM15202 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.25e-04 | 55 | 66 | 4 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.44e-04 | 57 | 66 | 4 | MM15643 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 1.62e-04 | 110 | 66 | 5 | MM15977 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 2.12e-04 | 63 | 66 | 4 | M27862 | |
| Pathway | KEGG_GLIOMA | 2.39e-04 | 65 | 66 | 4 | M1835 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 2.60e-04 | 270 | 66 | 7 | M15514 | |
| Pathway | PID_GLYPICAN_1PATHWAY | 2.65e-04 | 27 | 66 | 3 | M33 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 2.78e-04 | 273 | 66 | 7 | M983 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 3.19e-04 | 70 | 66 | 4 | M3115 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 4.15e-04 | 75 | 66 | 4 | M39568 | |
| Pathway | PID_NETRIN_PATHWAY | 4.41e-04 | 32 | 66 | 3 | M108 | |
| Pathway | BIOCARTA_TSP1_PATHWAY | 4.47e-04 | 7 | 66 | 2 | M22039 | |
| Pathway | BIOCARTA_TSP1_PATHWAY | 4.47e-04 | 7 | 66 | 2 | MM1559 | |
| Pathway | REACTOME_INTERLEUKIN_36_PATHWAY | 4.47e-04 | 7 | 66 | 2 | M27886 | |
| Pathway | REACTOME_INTERLEUKIN_36_PATHWAY | 4.47e-04 | 7 | 66 | 2 | MM15611 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 4.63e-04 | 138 | 66 | 5 | MM15635 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 4.94e-04 | 140 | 66 | 5 | M42572 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE | 5.94e-04 | 8 | 66 | 2 | M10546 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 7.29e-04 | 87 | 66 | 4 | M27617 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 7.29e-04 | 87 | 66 | 4 | M12467 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_LOCALIZATION | 7.61e-04 | 9 | 66 | 2 | M27814 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 7.62e-04 | 154 | 66 | 5 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 8.08e-04 | 156 | 66 | 5 | M39475 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 8.28e-04 | 90 | 66 | 4 | M835 | |
| Pathway | WP_ERBB_SIGNALING | 8.99e-04 | 92 | 66 | 4 | M39715 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 8.99e-04 | 92 | 66 | 4 | MM14951 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_LOCALIZATION | 9.48e-04 | 10 | 66 | 2 | MM15539 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.13e-03 | 44 | 66 | 3 | M875 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.27e-03 | 101 | 66 | 4 | M27253 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.37e-03 | 103 | 66 | 4 | MM15196 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.38e-03 | 176 | 66 | 5 | MM15718 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.46e-03 | 178 | 66 | 5 | M2890 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | 1.56e-03 | 472 | 66 | 8 | MM14539 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.64e-03 | 183 | 66 | 5 | M997 | |
| Pathway | REACTOME_LGI_ADAM_INTERACTIONS | 1.89e-03 | 14 | 66 | 2 | MM15277 | |
| Pathway | REACTOME_LGI_ADAM_INTERACTIONS | 1.89e-03 | 14 | 66 | 2 | M27564 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 1.92e-03 | 113 | 66 | 4 | M16817 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 1.92e-03 | 113 | 66 | 4 | M39669 | |
| Pathway | PID_TGFBR_PATHWAY | 2.05e-03 | 54 | 66 | 3 | M286 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 2.16e-03 | 55 | 66 | 3 | M39763 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 2.28e-03 | 56 | 66 | 3 | M27616 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.59e-03 | 203 | 66 | 5 | M5485 | |
| Pathway | BIOCARTA_BARRESTIN_SRC_PATHWAY | 2.81e-03 | 17 | 66 | 2 | M111 | |
| Pathway | BIOCARTA_BARRESTIN_SRC_PATHWAY | 2.81e-03 | 17 | 66 | 2 | MM1491 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 2.86e-03 | 126 | 66 | 4 | M16763 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.20e-03 | 130 | 66 | 4 | M27454 | |
| Pubmed | CACNG3 CACNG2 SHANK2 SV2A CAMK2A CAMK2B CAMK2D CAMK2G DNAJC11 DBNL APBA1 USP7 TRIOBP POR ADGRL1 PPP1R9B LASP1 PC NACAD PHACTR1 | 2.51e-12 | 1139 | 84 | 20 | 36417873 | |
| Pubmed | 3.17e-11 | 4 | 84 | 4 | 10381553 | ||
| Pubmed | Cadmium activates CaMK-II and initiates CaMK-II-dependent apoptosis in mesangial cells. | 3.17e-11 | 4 | 84 | 4 | 17367784 | |
| Pubmed | 3.17e-11 | 4 | 84 | 4 | 11889801 | ||
| Pubmed | 1.58e-10 | 5 | 84 | 4 | 11013247 | ||
| Pubmed | 1.58e-10 | 5 | 84 | 4 | 21209221 | ||
| Pubmed | 1.58e-10 | 5 | 84 | 4 | 14722083 | ||
| Pubmed | 1.58e-10 | 5 | 84 | 4 | 18218981 | ||
| Pubmed | Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B. | 1.58e-10 | 5 | 84 | 4 | 16436603 | |
| Pubmed | Multiple kinases regulate mafA expression in the pancreatic beta cell line MIN6. | 4.73e-10 | 6 | 84 | 4 | 18948074 | |
| Pubmed | Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. | 6.09e-10 | 18 | 84 | 5 | 18311135 | |
| Pubmed | Rad and Rad-related GTPases interact with calmodulin and calmodulin-dependent protein kinase II. | 1.10e-09 | 7 | 84 | 4 | 9115241 | |
| Pubmed | 2.20e-09 | 8 | 84 | 4 | 11264466 | ||
| Pubmed | 2.20e-09 | 8 | 84 | 4 | 20668654 | ||
| Pubmed | 3.95e-09 | 9 | 84 | 4 | 12660151 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 5.14e-09 | 231 | 84 | 9 | 16452087 | |
| Pubmed | 6.57e-09 | 10 | 84 | 4 | 19776387 | ||
| Pubmed | 6.57e-09 | 10 | 84 | 4 | 28361052 | ||
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 9882483 | ||
| Pubmed | Identification of novel human tumor cell-specific CaMK-II variants. | 1.36e-08 | 3 | 84 | 3 | 9060999 | |
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 10819240 | ||
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 20844140 | ||
| Pubmed | 1.54e-08 | 12 | 84 | 4 | 8615909 | ||
| Pubmed | 1.54e-08 | 12 | 84 | 4 | 8665664 | ||
| Pubmed | 1.54e-08 | 12 | 84 | 4 | 12815021 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | EP400 CAMK2B USP7 SH3GLB2 LASP1 GNAS PATJ TTC4 PGAM5 KDM1A PML MPRIP | 1.82e-08 | 588 | 84 | 12 | 38580884 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | CACNG2 SHANK2 CAMK2A CAMK2B CAMK2D CAMK2G PPP1R9B GNAS PHACTR1 | 2.80e-08 | 281 | 84 | 9 | 28706196 |
| Pubmed | 3.11e-08 | 14 | 84 | 4 | 10373510 | ||
| Pubmed | The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. | 4.23e-08 | 15 | 84 | 4 | 14622581 | |
| Pubmed | 4.23e-08 | 15 | 84 | 4 | 9481670 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | UTP6 THBS1 DSC3 CAMK2D CAMK2G DNAJC11 USP7 PDCD11 PPP1R9B GNAS PATJ TACSTD2 PGAM5 PML MPRIP NCOA5 | 4.87e-08 | 1257 | 84 | 16 | 36526897 |
| Pubmed | CACNG2 SHANK2 CAMK2A CAMK2B CAMK2D CAMK2G LRP1 TRIOBP PPP1R9B PGAM5 CUX1 KDM1A MPRIP PHACTR1 | 7.45e-08 | 963 | 84 | 14 | 28671696 | |
| Pubmed | TUBGCP6 PDE12 DSC3 NT5DC2 DNAJC11 PHACTR4 TRIOBP POR PDCD11 CPD GNAS ARFIP1 PGAM5 CUX1 MAST3 PML MPRIP | 8.22e-08 | 1487 | 84 | 17 | 33957083 | |
| Pubmed | EP400 PHACTR4 DBNL USP7 PDCD11 PATJ PC PGAM5 CUX1 KDM1A MPRIP | 9.02e-08 | 549 | 84 | 11 | 38280479 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | CAMK2A CAMK2B CAMK2G DBNL TRIOBP SH3GLB2 ADGRL1 PPP1R9B HOOK2 PML MPRIP | 1.10e-07 | 560 | 84 | 11 | 21653829 |
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 11160423 | ||
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 19671701 | ||
| Pubmed | PTENα Modulates CaMKII Signaling and Controls Contextual Fear Memory and Spatial Learning. | 1.35e-07 | 5 | 84 | 3 | 28636948 | |
| Pubmed | 1.79e-07 | 251 | 84 | 8 | 27507650 | ||
| Pubmed | 2.70e-07 | 6 | 84 | 3 | 16120608 | ||
| Pubmed | Requirement of Ca2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-gamma. | 2.70e-07 | 6 | 84 | 3 | 11972023 | |
| Pubmed | CERS2 DSC3 NT5DC2 DNAJC11 GORAB PHACTR4 POR CPD GNAS ARFIP2 ARFIP1 PGAM5 CUX1 | 4.64e-07 | 952 | 84 | 13 | 38569033 | |
| Pubmed | 4.72e-07 | 7 | 84 | 3 | 34932950 | ||
| Pubmed | The insulin receptor substrate of 53 kDa (IRSp53) limits hippocampal synaptic plasticity. | 7.18e-07 | 29 | 84 | 4 | 19208628 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SHANK2 DSC3 PHACTR4 DBNL SH3GLB2 LASP1 ARFIP2 PATJ ARFIP1 MPRIP | 1.11e-06 | 565 | 84 | 10 | 25468996 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | UTP6 PDE12 NT5DC2 CAMK2B ANXA6 DNAJC11 DBNL USP7 POR PDCD11 GNAS PC PGAM5 KDM1A NCOA5 | 1.48e-06 | 1425 | 84 | 15 | 30948266 |
| Pubmed | PCSK5 CAMK2B CAMK2G LRP1 KCNS2 CPD FGR KCNG3 FYN KDM1A CAPN11 | 1.49e-06 | 730 | 84 | 11 | 34857952 | |
| Pubmed | 1.61e-06 | 10 | 84 | 3 | 20124353 | ||
| Pubmed | 1.62e-06 | 233 | 84 | 7 | 29518331 | ||
| Pubmed | 2.04e-06 | 347 | 84 | 8 | 17114649 | ||
| Pubmed | 2.17e-06 | 472 | 84 | 9 | 38943005 | ||
| Pubmed | 2.21e-06 | 11 | 84 | 3 | 21491429 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 2.74e-06 | 361 | 84 | 8 | 30344098 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 3.35e-06 | 498 | 84 | 9 | 36634849 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UTP6 PDE12 WASHC4 DSC3 EP400 CAMK2D CAMK2G DBNL USP7 PDCD11 LASP1 PGAM5 KDM1A MPRIP | 4.23e-06 | 1353 | 84 | 14 | 29467282 |
| Pubmed | 4.67e-06 | 177 | 84 | 6 | 26485645 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 32149607 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 25650780 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 27496951 | ||
| Pubmed | Alterations of L-type calcium current and cardiac function in CaMKII{delta} knockout mice. | 5.76e-06 | 2 | 84 | 2 | 20538682 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 21305000 | ||
| Pubmed | TARP redundancy is critical for maintaining AMPA receptor function. | 5.76e-06 | 2 | 84 | 2 | 18753375 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 18703025 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 9523577 | ||
| Pubmed | Adipocyte CAMK2 deficiency improves obesity-associated glucose intolerance. | 5.76e-06 | 2 | 84 | 2 | 34303021 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 14991768 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 22348105 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 10221464 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 34908526 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 10693762 | ||
| Pubmed | De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability. | 5.76e-06 | 2 | 84 | 2 | 29100089 | |
| Pubmed | CaMKII is essential for the function of the enteric nervous system. | 5.76e-06 | 2 | 84 | 2 | 22952977 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 21252154 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 31619570 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 29992531 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 26567004 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 9045712 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 17154366 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 25124496 | ||
| Pubmed | NT5DC2 promotes tumorigenicity of glioma stem-like cells by upregulating fyn. | 5.76e-06 | 2 | 84 | 2 | 30978441 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 18804458 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24877199 | ||
| Pubmed | Recruitment of arfaptins to the trans-Golgi network by PI(4)P and their involvement in cargo export. | 5.76e-06 | 2 | 84 | 2 | 23695357 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 15294044 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 21884935 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 38597448 | ||
| Pubmed | CaMK-II oligomerization potential determined using CFP/YFP FRET. | 5.76e-06 | 2 | 84 | 2 | 16185778 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 17184923 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 11710563 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 25393517 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24223867 | ||
| Pubmed | Control of memory formation through regulated expression of a CaMKII transgene. | 5.76e-06 | 2 | 84 | 2 | 8939850 | |
| Pubmed | TARPs differentially decorate AMPA receptors to specify neuropharmacology. | 5.76e-06 | 2 | 84 | 2 | 20219255 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 23316062 | ||
| Pubmed | Bidirectional synaptic plasticity regulated by phosphorylation of stargazin-like TARPs. | 5.76e-06 | 2 | 84 | 2 | 15664178 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 21752990 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 25193973 | ||
| Pubmed | 6.13e-06 | 403 | 84 | 8 | 30562941 | ||
| Pubmed | Misregulation of Alternative Splicing in a Mouse Model of Rett Syndrome. | 6.17e-06 | 49 | 84 | 4 | 27352031 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CAMK2A CAMK2D PHACTR4 DBNL GNAS PATJ MAP3K21 PC FAM110B PML MPRIP | 7.20e-06 | 861 | 84 | 11 | 36931259 |
| Interaction | GRIN2B interactions | 3.74e-08 | 170 | 84 | 9 | int:GRIN2B | |
| Interaction | CAMK2N1 interactions | 5.79e-08 | 10 | 84 | 4 | int:CAMK2N1 | |
| Interaction | AGAP2 interactions | SHANK2 CAMK2A CAMK2B CAMK2D CAMK2G PPP1R9B GNAS MPRIP PHACTR1 | 2.29e-07 | 210 | 84 | 9 | int:AGAP2 |
| Interaction | CAMK2A interactions | CACNG2 CAMK2A CAMK2B CAMK2D CAMK2G DBNL USP7 PPP1R9B LASP1 PATJ | 2.47e-07 | 279 | 84 | 10 | int:CAMK2A |
| Interaction | GRIN1 interactions | 2.58e-07 | 154 | 84 | 8 | int:GRIN1 | |
| Interaction | DLG4 interactions | CACNG3 CACNG2 SHANK2 CAMK2A CAMK2B CAMK2D APBA1 LRP1 ADGRL1 PPP1R9B FYN PGAM5 | 3.42e-07 | 449 | 84 | 12 | int:DLG4 |
| Interaction | KRTAP19-3 interactions | 8.22e-07 | 18 | 84 | 4 | int:KRTAP19-3 | |
| Interaction | DLGAP1 interactions | 8.47e-07 | 180 | 84 | 8 | int:DLGAP1 | |
| Interaction | CIBAR2 interactions | 2.42e-06 | 7 | 84 | 3 | int:CIBAR2 | |
| Interaction | CAMK2N2 interactions | 2.42e-06 | 7 | 84 | 3 | int:CAMK2N2 | |
| Interaction | NF1 interactions | 6.77e-06 | 238 | 84 | 8 | int:NF1 | |
| Interaction | PDE4A interactions | 7.09e-06 | 30 | 84 | 4 | int:PDE4A | |
| Interaction | CAMK2G interactions | 7.20e-06 | 240 | 84 | 8 | int:CAMK2G | |
| Interaction | WWTR1 interactions | 1.01e-05 | 422 | 84 | 10 | int:WWTR1 | |
| Interaction | CAMK2B interactions | 1.10e-05 | 182 | 84 | 7 | int:CAMK2B | |
| Interaction | ITPR2 interactions | 1.15e-05 | 121 | 84 | 6 | int:ITPR2 | |
| Interaction | CALM3 interactions | 1.29e-05 | 343 | 84 | 9 | int:CALM3 | |
| Interaction | MAPT interactions | PDE12 SV2A CAMK2A NT5DC2 CAMK2B CAMK2D CAMK2G ANXA6 DBNL APBA1 USP7 SH3GLB2 LASP1 GNAS FYN KDM1A | 1.31e-05 | 1119 | 84 | 16 | int:MAPT |
| Interaction | CALD1 interactions | 1.48e-05 | 265 | 84 | 8 | int:CALD1 | |
| Interaction | STAT3 interactions | 1.63e-05 | 446 | 84 | 10 | int:STAT3 | |
| Interaction | ELOVL5 interactions | 2.07e-05 | 364 | 84 | 9 | int:ELOVL5 | |
| Interaction | YES1 interactions | 2.62e-05 | 375 | 84 | 9 | int:YES1 | |
| Interaction | GRIA1 interactions | 2.98e-05 | 86 | 84 | 5 | int:GRIA1 | |
| Interaction | SH2D1A interactions | 3.67e-05 | 45 | 84 | 4 | int:SH2D1A | |
| Interaction | ZNF280A interactions | 3.76e-05 | 16 | 84 | 3 | int:ZNF280A | |
| Interaction | CAMK2D interactions | 3.95e-05 | 222 | 84 | 7 | int:CAMK2D | |
| Interaction | GRIN2A interactions | 4.35e-05 | 93 | 84 | 5 | int:GRIN2A | |
| Interaction | KALRN interactions | 5.06e-05 | 96 | 84 | 5 | int:KALRN | |
| Interaction | RHOU interactions | 5.09e-05 | 510 | 84 | 10 | int:RHOU | |
| Interaction | FAM163B interactions | 5.45e-05 | 18 | 84 | 3 | int:FAM163B | |
| Interaction | STRN3 interactions | 5.76e-05 | 161 | 84 | 6 | int:STRN3 | |
| Interaction | SKAP2 interactions | 6.04e-05 | 51 | 84 | 4 | int:SKAP2 | |
| Interaction | NRP1 interactions | 6.18e-05 | 324 | 84 | 8 | int:NRP1 | |
| Interaction | RGS14 interactions | 6.47e-05 | 240 | 84 | 7 | int:RGS14 | |
| Interaction | TIRAP interactions | 7.04e-05 | 53 | 84 | 4 | int:TIRAP | |
| Interaction | EZHIP interactions | 7.57e-05 | 20 | 84 | 3 | int:EZHIP | |
| Interaction | SENP5 interactions | 1.07e-04 | 59 | 84 | 4 | int:SENP5 | |
| Interaction | TTC5 interactions | 1.57e-04 | 65 | 84 | 4 | int:TTC5 | |
| Interaction | FBN2 interactions | 1.57e-04 | 65 | 84 | 4 | int:FBN2 | |
| Interaction | YAP1 interactions | CERS2 THBS1 DBNL USP7 TRIOBP GNAS PATJ PC ARFIP1 PGAM5 CUX1 KDM1A PML MPRIP | 1.62e-04 | 1095 | 84 | 14 | int:YAP1 |
| Interaction | HASPIN interactions | 1.64e-04 | 123 | 84 | 5 | int:HASPIN | |
| Interaction | CNKSR2 interactions | 1.66e-04 | 66 | 84 | 4 | int:CNKSR2 | |
| Interaction | RHOB interactions | DSC3 PHACTR4 TRIOBP ADGRL1 CPD GNAS PATJ MAP3K21 IL1RAP ARFIP1 FYN MPRIP | 1.82e-04 | 840 | 84 | 12 | int:RHOB |
| Interaction | CEP41 interactions | 2.12e-04 | 28 | 84 | 3 | int:CEP41 | |
| Interaction | TIAM1 interactions | 2.16e-04 | 205 | 84 | 6 | int:TIAM1 | |
| Interaction | MAP10 interactions | 2.36e-04 | 29 | 84 | 3 | int:MAP10 | |
| Interaction | PAK6 interactions | 2.46e-04 | 73 | 84 | 4 | int:PAK6 | |
| Interaction | RAC3 interactions | MYO10 PHACTR4 TRIOBP POR ADGRL1 CPD GNAS ARFIP2 MAP3K21 ARFIP1 | 2.48e-04 | 619 | 84 | 10 | int:RAC3 |
| Interaction | BAG2 interactions | TUBGCP6 WASHC4 MYO10 CAMK2A DNAJC11 PHACTR4 DBNL FGR ARFIP1 PML | 2.58e-04 | 622 | 84 | 10 | int:BAG2 |
| Interaction | CALM1 interactions | MYO10 CAMK2A CAMK2B CAMK2D CAMK2G ESRRG PHACTR4 GNAS ARFIP2 PML | 2.72e-04 | 626 | 84 | 10 | int:CALM1 |
| Interaction | CD2AP interactions | 2.73e-04 | 214 | 84 | 6 | int:CD2AP | |
| Interaction | RHOH interactions | 2.79e-04 | 512 | 84 | 9 | int:RHOH | |
| Interaction | SYNGAP1 interactions | 2.96e-04 | 307 | 84 | 7 | int:SYNGAP1 | |
| Interaction | HOMER1 interactions | 2.99e-04 | 140 | 84 | 5 | int:HOMER1 | |
| Interaction | YWHAZ interactions | MST1R DSC3 CAMK2A CAMK2B CAMK2D SPEG CAMK2G PHACTR4 PPP1R9B PFKFB4 ZCCHC7 MAP3K21 MAST3 PML MPRIP | 3.29e-04 | 1319 | 84 | 15 | int:YWHAZ |
| Interaction | CDH1 interactions | SHANK2 DSC3 PHACTR4 DBNL SH3GLB2 LASP1 ARFIP2 PATJ ARFIP1 FYN MPRIP | 3.37e-04 | 768 | 84 | 11 | int:CDH1 |
| Interaction | TMPRSS11B interactions | 3.42e-04 | 416 | 84 | 8 | int:TMPRSS11B | |
| Interaction | CDC37 interactions | 3.45e-04 | 645 | 84 | 10 | int:CDC37 | |
| Interaction | CACNG2 interactions | 3.48e-04 | 33 | 84 | 3 | int:CACNG2 | |
| Interaction | HIF1AN interactions | 3.59e-04 | 317 | 84 | 7 | int:HIF1AN | |
| Interaction | BIRC3 interactions | UTP6 PDE12 NT5DC2 CAMK2B ANXA6 DNAJC11 DBNL USP7 POR PDCD11 GNAS PC PGAM5 KDM1A NCOA5 | 3.71e-04 | 1334 | 84 | 15 | int:BIRC3 |
| Interaction | RHOA interactions | CERS2 DSC3 PHACTR4 POR SH3GLB2 PDCD11 ADGRL1 PPP1R9B CPD GNAS PATJ ARFIP1 FYN MPRIP | 4.09e-04 | 1199 | 84 | 14 | int:RHOA |
| Interaction | UBXN6 interactions | 4.16e-04 | 325 | 84 | 7 | int:UBXN6 | |
| Interaction | LIMA1 interactions | 4.19e-04 | 429 | 84 | 8 | int:LIMA1 | |
| Interaction | STRN interactions | 4.64e-04 | 154 | 84 | 5 | int:STRN | |
| Interaction | TNPO3 interactions | 4.70e-04 | 237 | 84 | 6 | int:TNPO3 | |
| Interaction | SLC6A4 interactions | 4.74e-04 | 437 | 84 | 8 | int:SLC6A4 | |
| Interaction | DYRK1A interactions | 4.83e-04 | 552 | 84 | 9 | int:DYRK1A | |
| Interaction | CCT8L2 interactions | 5.06e-04 | 157 | 84 | 5 | int:CCT8L2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p13 | 1.30e-04 | 53 | 84 | 3 | chr7p13 | |
| Cytoband | 10q24.33 | 2.16e-04 | 12 | 84 | 2 | 10q24.33 | |
| Cytoband | 3q28 | 1.39e-03 | 30 | 84 | 2 | 3q28 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q28 | 2.00e-03 | 36 | 84 | 2 | chr3q28 | |
| Cytoband | 7p13 | 2.35e-03 | 39 | 84 | 2 | 7p13 | |
| Cytoband | 12q24.33 | 3.53e-03 | 48 | 84 | 2 | 12q24.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q24 | 5.12e-03 | 189 | 84 | 3 | chr10q24 | |
| Cytoband | 1q41 | 6.58e-03 | 66 | 84 | 2 | 1q41 | |
| GeneFamily | PDZ domain containing | 1.21e-05 | 152 | 61 | 6 | 1220 | |
| GeneFamily | Phosphatase and actin regulators | 6.69e-05 | 4 | 61 | 2 | 679 | |
| GeneFamily | Classical BAR domain containing | 3.09e-04 | 8 | 61 | 2 | 1292 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 1.14e-03 | 15 | 61 | 2 | 1296 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.45e-03 | 26 | 61 | 2 | 253 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | TGFB2 PCSK5 MST1R THBS1 FBN2 SPEG ANXA6 ESRRG GORAB TRIOBP ADGRL1 PFKFB4 SVEP1 FAM110B PHACTR1 | 3.96e-05 | 1148 | 84 | 15 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | TGFB2 PCSK5 THBS1 FBN2 SV2A P3H2 NEXMIF ANXA6 LRP1 IL1RL2 SVEP1 CUX1 | 5.33e-05 | 777 | 84 | 12 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | TGFB2 PCSK5 THBS1 MYO10 SV2A P3H2 NT5DC2 LRP1 LASP1 FYN IL1RL2 SVEP1 | 6.48e-05 | 793 | 84 | 12 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.LC.Sk, MHCII+ CD11b+ CD45+, Skin, avg-2 | 7.31e-05 | 451 | 84 | 9 | GSM538280_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 8.30e-05 | 356 | 84 | 8 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 6.15e-08 | 185 | 84 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.12e-08 | 189 | 84 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-07 | 200 | 84 | 7 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-07 | 200 | 84 | 7 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-07 | 200 | 84 | 7 | dc674124475edf83908b51a4e1454bc2dc4f06fa | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.57e-06 | 189 | 84 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.94e-06 | 196 | 84 | 6 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.62e-05 | 167 | 84 | 5 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.62e-05 | 167 | 84 | 5 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 168 | 84 | 5 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-05 | 171 | 84 | 5 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.92e-05 | 173 | 84 | 5 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC-DC1|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.02e-05 | 175 | 84 | 5 | 398e2504021f587166ad04a2f0662bfcb4e1c0df | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-05 | 176 | 84 | 5 | 07abf29d681abdd6c7cc87f9eaf9377e92ce212c | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_activate-7|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.08e-05 | 176 | 84 | 5 | dde46f06f6fc3f7ba83be91a0ee6231790955e3e | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-05 | 177 | 84 | 5 | eb0cfe8e9a91910f9979608ed47add48d98ce4dd | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-05 | 178 | 84 | 5 | 5d6297f34e104bacefb25c4e2338b50fe13dd19a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 179 | 84 | 5 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 2.32e-05 | 180 | 84 | 5 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 2.38e-05 | 181 | 84 | 5 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.44e-05 | 182 | 84 | 5 | 1d37c486173cc4629842893ddd5033987c04086f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-05 | 182 | 84 | 5 | 1647367b75b4b107af06bb934394168230cfd7c2 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.44e-05 | 182 | 84 | 5 | aef67bdc6937b315522d39959e26c9b0acf7ab52 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.44e-05 | 182 | 84 | 5 | 087c9f88daf08f5d688b728c2386f91f210d2255 | |
| ToppCell | E12.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.44e-05 | 182 | 84 | 5 | 204530444e35d4977a7239ac176f477e9e5c29ab | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.57e-05 | 184 | 84 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.78e-05 | 187 | 84 | 5 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 2.78e-05 | 187 | 84 | 5 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.85e-05 | 188 | 84 | 5 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 2.85e-05 | 188 | 84 | 5 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.85e-05 | 188 | 84 | 5 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.85e-05 | 188 | 84 | 5 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.85e-05 | 188 | 84 | 5 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.93e-05 | 189 | 84 | 5 | a59025e82fabd9d60e2438dee85b2644478cc7c8 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.93e-05 | 189 | 84 | 5 | e2bb5900d210386b7b74938e7a3636d0c7ba1bcf | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 3.00e-05 | 190 | 84 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.00e-05 | 190 | 84 | 5 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 3.00e-05 | 190 | 84 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.08e-05 | 191 | 84 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | CV-Moderate-0|Moderate / Virus stimulation, Condition and Cluster | 3.08e-05 | 191 | 84 | 5 | 6776bcc4c1915f0c1062002ff7746f20ceb725f4 | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.08e-05 | 191 | 84 | 5 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.08e-05 | 191 | 84 | 5 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.16e-05 | 192 | 84 | 5 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.23e-05 | 193 | 84 | 5 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.23e-05 | 193 | 84 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-05 | 193 | 84 | 5 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-Naive_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 3.32e-05 | 194 | 84 | 5 | 20967afbadb3cf80ba9f4d7ebda4e64389252e70 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.32e-05 | 194 | 84 | 5 | 08fad7591c20568de797cf8e206de2d0b1d78aab | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-05 | 194 | 84 | 5 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.40e-05 | 195 | 84 | 5 | d67a2b489c29bfd575751c13d2a5b1efdec5240a | |
| ToppCell | P07-Mesenchymal|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.40e-05 | 195 | 84 | 5 | 859764b605866b6c3e6edd0698670ca9c0f20745 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.40e-05 | 195 | 84 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.57e-05 | 197 | 84 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.65e-05 | 198 | 84 | 5 | cc2b5b632e73e44bb60050f0db10d8f0dbb859fa | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.74e-05 | 199 | 84 | 5 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | Sepsis-URO|Sepsis / Disease, condition lineage and cell class | 3.74e-05 | 199 | 84 | 5 | 8e6dac82d1d0e759cd567f9c95b70cb4801d7caf | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 3.74e-05 | 199 | 84 | 5 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | severe-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.83e-05 | 200 | 84 | 5 | 0e86f52b6e146d9bbc728d8fb176fc2b53696558 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | 63a5ae71cfc2aa878a0cea58bdf99da7534b3551 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | 09bac15df511687ff336c1e7a67d980c6c281f79 | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.07e-04 | 130 | 84 | 4 | a3e12984fb61311e49cc76c59f74f4dffc48faa1 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 1.31e-04 | 137 | 84 | 4 | a1e34ebbeda3d5a4f14917282d44fcb4dcbf3133 | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 1.47e-04 | 141 | 84 | 4 | 7671d300b1722711fd2d8034b96a3aa7e3ccb560 | |
| ToppCell | COVID-19_Mild-PLT_3|World / Disease Group and Platelet Clusters | 1.72e-04 | 147 | 84 | 4 | 9d3271aa735ddb6f32ab864d7afcfb0f8754383b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.96e-04 | 152 | 84 | 4 | b6a7453fbf9f898e4f222b215907c9a110baa2f6 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 157 | 84 | 4 | 3cffedafff31efb5b3259194157b54a768367459 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 157 | 84 | 4 | f87e867a394b0453ebd92c592e80450caf5902cb | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.38e-04 | 160 | 84 | 4 | f843287ed57d2d5a3b3f6dfb03b6934e330e6645 | |
| ToppCell | PBMC-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 2.38e-04 | 160 | 84 | 4 | 4dac64e58d9366c399f3d830848ccb720d400be7 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.44e-04 | 161 | 84 | 4 | ebcd5066e82b7760b9da6adc02d11258d1309dab | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.44e-04 | 161 | 84 | 4 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.50e-04 | 162 | 84 | 4 | 9c9a63adb692651ea5a52cc77b02c5ce11d0ccea | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 162 | 84 | 4 | dddf7a3901ae59e3494d8a6740db0fa15cc96d47 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.50e-04 | 162 | 84 | 4 | 1d29983b22f963b34e72cfd1eec328d2d7c4932f | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 162 | 84 | 4 | 2a4e09545e9874519f0f56e81065104987d81cd6 | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.56e-04 | 163 | 84 | 4 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.62e-04 | 164 | 84 | 4 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 166 | 84 | 4 | ec7bd549bda5f18aca8aebce5ba479a81abbbeda | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.74e-04 | 166 | 84 | 4 | b1bebcbe17386cb102b11d551e62d46156ce0c68 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.80e-04 | 167 | 84 | 4 | e44743b20a7435c579d8e999ddc4ca119d6753f2 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.93e-04 | 169 | 84 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.00e-04 | 170 | 84 | 4 | 9ac1ef57f14418a5dd2aa16861c3df698c28f5ed | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.00e-04 | 170 | 84 | 4 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-granulocyte|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-04 | 170 | 84 | 4 | 8fd0a55266066a51266ab616c38c883e2680bcf4 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-04 | 170 | 84 | 4 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.00e-04 | 170 | 84 | 4 | 403b6b749d70d845838dcda7daf99971b50792a2 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 171 | 84 | 4 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC1|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.07e-04 | 171 | 84 | 4 | 04346d4eb726875e3537e215ea081a0318ca4ddd | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 171 | 84 | 4 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Monocytic|GI_small-bowel / Manually curated celltypes from each tissue | 3.07e-04 | 171 | 84 | 4 | 098a7fd387357c0d4e1a6169af4d24ef95b30018 | |
| ToppCell | droplet-Fat-Scat-18m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 172 | 84 | 4 | 8a4a5ad65eec92ce4fa45c5aa01c28666307455b | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 3.21e-04 | 173 | 84 | 4 | 783b8fa08b9d8f597f251793eae164151662f1f9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.28e-04 | 174 | 84 | 4 | 9cc7251661ea2b1565eef1dfb8cf6dec3ade13d4 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intermediate_macrophages|bone_marrow / Manually curated celltypes from each tissue | 3.28e-04 | 174 | 84 | 4 | 268abfc4d53a3ba3931dbcafffef09a72ea0edfa | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Monocytic-Classical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue | 3.28e-04 | 174 | 84 | 4 | 05d54a36772f096047521e16a89cc42ae48d2a1d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-04 | 174 | 84 | 4 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | Severe-B_naive-8|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.28e-04 | 174 | 84 | 4 | f3f8c924420f46321bd47e2b97f18c7241541599 | |
| Drug | sunitinib | 5.29e-07 | 130 | 84 | 7 | CID005329102 | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; PC3; HT_HG-U133A | 7.31e-07 | 199 | 84 | 8 | 5844_DN | |
| Drug | N-methyl-DL-aspartic acid | CACNG3 CACNG2 TGFB2 SHANK2 CAMK2A CAMK2B CAMK2D CAMK2G APBA1 LRP1 PPP1R9B GNAS FYN | 7.88e-07 | 655 | 84 | 13 | CID000004376 |
| Drug | HF-2035 | 2.06e-06 | 25 | 84 | 4 | CID006439511 | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 6.42e-06 | 189 | 84 | 7 | 5455_UP | |
| Drug | prochloraz | 6.68e-06 | 268 | 84 | 8 | ctd:C045362 | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 1uM; MCF7; HT_HG-U133A | 7.36e-06 | 193 | 84 | 7 | 3908_DN | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 7.62e-06 | 194 | 84 | 7 | 5278_DN | |
| Drug | camphene | 7.82e-06 | 11 | 84 | 3 | CID000006616 | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 8.14e-06 | 196 | 84 | 7 | 7356_DN | |
| Drug | Te Al | 8.27e-06 | 35 | 84 | 4 | CID000168005 | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; PC3; HT_HG-U133A | 8.70e-06 | 198 | 84 | 7 | 6603_DN | |
| Drug | Tenoxicam [59804-37-4]; Up 200; 11.8uM; PC3; HT_HG-U133A | 8.70e-06 | 198 | 84 | 7 | 4102_UP | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 8.70e-06 | 198 | 84 | 7 | 4722_DN | |
| Drug | procymidone | 2.37e-05 | 155 | 84 | 6 | ctd:C035988 | |
| Drug | epoxiconazole | 3.78e-05 | 341 | 84 | 8 | ctd:C109476 | |
| Drug | GW 7845 | 3.80e-05 | 18 | 84 | 3 | ctd:C401311 | |
| Drug | muraglitazar | 3.80e-05 | 444 | 84 | 9 | ctd:C500085 | |
| Drug | Haloperidol | 3.86e-05 | 342 | 84 | 8 | ctd:D006220 | |
| Drug | 2-methylindoline | 5.28e-05 | 20 | 84 | 3 | CID000023305 | |
| Drug | Muurola-4,9-diene | 8.03e-05 | 4 | 84 | 2 | CID000101708 | |
| Drug | CID9572853 | 8.03e-05 | 4 | 84 | 2 | CID009572853 | |
| Drug | Vitamin K2 [11032-49-8]; Up 200; 9uM; MCF7; HT_HG-U133A | 8.06e-05 | 193 | 84 | 6 | 3880_UP | |
| Drug | Carbamazepine [298-46-4]; Up 200; 17uM; PC3; HT_HG-U133A | 8.29e-05 | 194 | 84 | 6 | 1805_UP | |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; HL60; HT_HG-U133A | 8.53e-05 | 195 | 84 | 6 | 2907_UP | |
| Drug | Estropipate [7280-37-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 8.53e-05 | 195 | 84 | 6 | 6808_UP | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 8.77e-05 | 196 | 84 | 6 | 5919_UP | |
| Drug | Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; PC3; HT_HG-U133A | 8.77e-05 | 196 | 84 | 6 | 4283_UP | |
| Drug | Ketoprofen [22071-15-4]; Up 200; 15.8uM; PC3; HT_HG-U133A | 8.77e-05 | 196 | 84 | 6 | 3729_UP | |
| Drug | Protoveratrine A [143-57-7]; Up 200; 5uM; MCF7; HT_HG-U133A | 8.77e-05 | 196 | 84 | 6 | 2800_UP | |
| Drug | Panthenol (D) [81-13-0]; Up 200; 19.4uM; PC3; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 1802_UP | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 6265_UP | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; PC3; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 4477_DN | |
| Drug | Procaine hydrochloride [51-05-8]; Up 200; 14.6uM; PC3; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 1796_UP | |
| Drug | Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; PC3; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 5770_DN | |
| Drug | Droperidol [548-73-2]; Up 200; 10.6uM; PC3; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 4629_UP | |
| Drug | Oxyphenbutazone [129-20-4]; Down 200; 12.4uM; PC3; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 4506_DN | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 7505_UP | |
| Drug | Levamisole hydrochloride [16595-80-5]; Up 200; 16.6uM; PC3; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 2094_UP | |
| Drug | PHA-00816795 [212631-79-3]; Up 200; 10uM; PC3; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 7076_UP | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 4358_UP | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; HL60; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 2725_UP | |
| Drug | Phensuximide [86-34-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 3521_UP | |
| Drug | Cefaclor [70356-03-5]; Down 200; 10.4uM; PC3; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 6622_DN | |
| Drug | Pepstatin A [26305-03-3]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 9.54e-05 | 199 | 84 | 6 | 3264_UP | |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 9.54e-05 | 199 | 84 | 6 | 3345_DN | |
| Drug | Molsidomine [25717-80-0]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 9.54e-05 | 199 | 84 | 6 | 2862_DN | |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; PC3; HT_HG-U133A | 9.54e-05 | 199 | 84 | 6 | 6652_DN | |
| Drug | iloprost; Up 200; 1uM; SKMEL5; HG-U133A | 9.54e-05 | 199 | 84 | 6 | 496_UP | |
| Drug | Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; HL60; HT_HG-U133A | 9.54e-05 | 199 | 84 | 6 | 3017_DN | |
| Drug | Spironolactone [52-01-7]; Down 200; 9.6uM; PC3; HT_HG-U133A | 9.54e-05 | 199 | 84 | 6 | 5781_DN | |
| Drug | tesaglitazar | 9.74e-05 | 502 | 84 | 9 | ctd:C501413 | |
| Drug | Orlistat; Down 200; 10uM; MCF7; HT_HG-U133A | 9.81e-05 | 200 | 84 | 6 | 6415_DN | |
| Drug | valdecoxib; Up 200; 10uM; MCF7; HT_HG-U133A | 9.81e-05 | 200 | 84 | 6 | 6403_UP | |
| Drug | Clidinium bromide [3485-62-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 9.81e-05 | 200 | 84 | 6 | 6837_UP | |
| Drug | Linuron | 1.12e-04 | 128 | 84 | 5 | ctd:D008044 | |
| Drug | SB-C | 1.24e-04 | 69 | 84 | 4 | CID005331010 | |
| Drug | phthalonitrile | 2.00e-04 | 6 | 84 | 2 | CID000007042 | |
| Drug | AC1L1VI4 | 2.02e-04 | 31 | 84 | 3 | CID000010580 | |
| Disease | heart conduction disease (implicated_via_orthology) | 1.79e-06 | 32 | 81 | 4 | DOID:10273 (implicated_via_orthology) | |
| Disease | Schizophrenia | CACNG2 THBS1 SV2A HLA-DQB1 CAMK2B LRP1 PPP1R9B LASP1 GNAS FYN LMOD2 PML | 5.09e-06 | 883 | 81 | 12 | C0036341 |
| Disease | mean arterial pressure | 9.34e-06 | 499 | 81 | 9 | EFO_0006340 | |
| Disease | cortical surface area measurement | INTU THBS1 FBN2 NT5DC2 TRIOBP PPP1R9B HOOK2 PC SVEP1 CUX1 KDM1A STN1 MPRIP | 7.23e-05 | 1345 | 81 | 13 | EFO_0010736 |
| Disease | migraine without aura | 7.40e-05 | 5 | 81 | 2 | MONDO_0100431 | |
| Disease | Common Migraine | 1.55e-04 | 7 | 81 | 2 | C0338480 | |
| Disease | thyroid carcinoma | 1.70e-04 | 39 | 81 | 3 | EFO_0002892 | |
| Disease | Anorectal Malformations | 1.97e-04 | 41 | 81 | 3 | C3495676 | |
| Disease | bitter beverage consumption measurement | 2.12e-04 | 42 | 81 | 3 | EFO_0010089 | |
| Disease | fibromuscular dysplasia | 2.43e-04 | 44 | 81 | 3 | EFO_1000938 | |
| Disease | pulse pressure measurement, migraine without aura, susceptibility to, 4 | 2.65e-04 | 9 | 81 | 2 | EFO_0005763, MONDO_0011847 | |
| Disease | aortic aneurysm | 3.30e-04 | 10 | 81 | 2 | EFO_0001666 | |
| Disease | smoking behavior, BMI-adjusted waist circumference | 3.62e-04 | 122 | 81 | 4 | EFO_0004318, EFO_0007789 | |
| Disease | chronic bronchitis | 4.03e-04 | 11 | 81 | 2 | EFO_0006505 | |
| Disease | peak expiratory flow | 4.43e-04 | 498 | 81 | 7 | EFO_0009718 | |
| Disease | white matter integrity | 4.60e-04 | 130 | 81 | 4 | EFO_0004641 | |
| Disease | ADHD symptom measurement | 4.83e-04 | 12 | 81 | 2 | EFO_0007860 | |
| Disease | FEV/FEC ratio | TGFB2 UTP6 PCSK5 HLA-DQB1 SPEG CAMK2G ESRRG LRP1 ARFIP1 CUX1 PML | 5.20e-04 | 1228 | 81 | 11 | EFO_0004713 |
| Disease | diabetic retinopathy | 5.46e-04 | 136 | 81 | 4 | EFO_0003770 | |
| Disease | physical activity measurement | 5.81e-04 | 245 | 81 | 5 | EFO_0008002 | |
| Disease | psoriasis vulgaris | 6.39e-04 | 61 | 81 | 3 | EFO_1001494 | |
| Disease | chronotype measurement | 6.97e-04 | 882 | 81 | 9 | EFO_0008328 | |
| Disease | Headache | 7.36e-04 | 64 | 81 | 3 | HP_0002315 | |
| Disease | urate measurement | 7.73e-04 | 895 | 81 | 9 | EFO_0004531 | |
| Disease | migraine without aura, susceptibility to, 4 | 8.71e-04 | 16 | 81 | 2 | MONDO_0011847 | |
| Disease | psoriasis | 9.44e-04 | 273 | 81 | 5 | EFO_0000676 | |
| Disease | cervical artery dissection | 9.85e-04 | 17 | 81 | 2 | EFO_1000059 | |
| Disease | platelet component distribution width | 1.10e-03 | 755 | 81 | 8 | EFO_0007984 | |
| Disease | energy expenditure measurement | 1.37e-03 | 20 | 81 | 2 | EFO_0008005 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.45e-03 | 301 | 81 | 5 | DOID:684 (is_marker_for) | |
| Disease | forced expiratory volume | 1.45e-03 | 789 | 81 | 8 | EFO_0004314 | |
| Disease | Antimigraine preparation use measurement | 1.51e-03 | 21 | 81 | 2 | EFO_0009939 | |
| Disease | cholangiocarcinoma (is_implicated_in) | 1.66e-03 | 22 | 81 | 2 | DOID:4947 (is_implicated_in) | |
| Disease | basal cell carcinoma | 1.85e-03 | 189 | 81 | 4 | EFO_0004193 | |
| Disease | body surface area | 1.95e-03 | 643 | 81 | 7 | EFO_0022196 | |
| Disease | Bipolar Disorder | 2.02e-03 | 477 | 81 | 6 | C0005586 | |
| Disease | migraine disorder, pulse pressure measurement | 2.32e-03 | 26 | 81 | 2 | EFO_0005763, MONDO_0005277 | |
| Disease | Bone Diseases, Developmental | 2.50e-03 | 27 | 81 | 2 | C0005941 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 2.59e-03 | 99 | 81 | 3 | DOID:11446 (biomarker_via_orthology) | |
| Disease | neuroblastoma, cutaneous melanoma | 2.69e-03 | 28 | 81 | 2 | EFO_0000389, EFO_0000621 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEAELLTYTREDAYS | 2216 | Q96L91 | |
| YVLRSVYVDDDSEAA | 326 | O94910 | |
| ESARIEYDAYRTDLE | 261 | P53367 | |
| DADYEQDTAEYLLRA | 86 | O60359 | |
| ARLEYDAYRTDLEEL | 231 | P53365 | |
| ARYADDDLIIDFDSF | 686 | Q9UMQ6 | |
| EDRDGRVYAKASDLY | 26 | Q96G23 | |
| VAAYKDAYERDLEAD | 131 | P08133 | |
| DYSYARKRFDRAEAE | 216 | Q5T7V8 | |
| CDDYDRERNEYFFDR | 51 | Q8TAE7 | |
| DADYEADTAEYFLRA | 86 | Q9Y698 | |
| TDLFDRYDEEYEDVS | 136 | Q9NVH1 | |
| ADQSLRYYRDSVAEE | 411 | Q6WCQ1 | |
| RYYRDSVAEEAADLD | 416 | Q6WCQ1 | |
| CRRSDEDYLYREELA | 566 | P16435 | |
| LFIALYDYEARTEDD | 81 | P09769 | |
| DIYVSYARNAEEEEF | 406 | Q9NPH3 | |
| RYYFLSEEAEEGDEL | 176 | Q96ED9 | |
| IDARSDAIYSARYDG | 1451 | Q07954 | |
| RYRAVYDYSAADEDE | 206 | Q14847 | |
| YRRGLSKYESIDEDE | 6 | Q6P5Q4 | |
| DTELRYSSQYEERLD | 566 | Q13948 | |
| LEYLYLSVHDEDRDD | 86 | O43237 | |
| SFEEDQVIEYRDRDY | 1801 | Q92824 | |
| QVIEYRDRDYDEDDD | 1806 | Q92824 | |
| YIHRADARQEEDSYE | 211 | Q96HS1 | |
| YYREEAVAEDVLNVD | 126 | Q6L8Q7 | |
| RRESFLYRSDSDYEL | 116 | Q08493 | |
| DDSYFDRYRDSFDGR | 141 | Q9HCD5 | |
| SYESLDEDLDRDLSY | 201 | Q16877 | |
| LELCDDYDDVQREFY | 56 | Q9ULS6 | |
| DFDSRFDTDDELSYR | 1151 | Q9HD67 | |
| FDTDDELSYRRDSVY | 1156 | Q9HD67 | |
| EELDDDFSYARELRD | 726 | Q96RT7 | |
| YSGDYERAVRDLEAA | 56 | Q8IVL5 | |
| ESENYYEFDVRARDG | 311 | Q9Y5F7 | |
| EYVEVTDAQDYDRRA | 646 | Q8IZ21 | |
| RFSDYVEVADAQDYD | 521 | Q9C0D0 | |
| ADFAELSEDYYDMRR | 496 | Q9ULD6 | |
| DDYYDESKRIREGVE | 271 | Q9HB29 | |
| REEYARFDSDVEVYR | 66 | P01920 | |
| SEDEYYSEEERNAKA | 131 | O60341 | |
| VDREEYDVFDLIAYA | 201 | Q14574 | |
| GESRYLELREAADYD | 21 | P24387 | |
| RSLSFEDELVYADDY | 316 | P62508 | |
| LFVALYDYEARTEDD | 86 | P06241 | |
| DRYYHEEELESALRE | 56 | O75976 | |
| YEQERDEAAAYRQEA | 216 | Q02410 | |
| LAFSISYDRGEEEAY | 626 | Q96BJ8 | |
| AEDDTSYFDTRSERY | 661 | O60307 | |
| SDLSDRYFRVDADVE | 261 | Q8TC76 | |
| YYLSEDTRICEDIDE | 1681 | P35556 | |
| ARALYDYQAADDTEI | 376 | Q9UJU6 | |
| GELFEDIVAREYYSE | 96 | Q13555 | |
| GELFEDIVAREYYSE | 96 | Q13557 | |
| GELFEDIVAREYYSE | 96 | Q13554 | |
| EYYERALREFGSADS | 531 | Q9NYH9 | |
| VRERDAFYSYGVDDS | 66 | Q9H668 | |
| LYDYEARGEDELSLR | 46 | Q5TCX8 | |
| DVDIGDAAYYFERDI | 216 | P09758 | |
| VRYSEDYLYDVDSLE | 486 | Q5QGS0 | |
| ELLEAVDARYQRDYE | 296 | P29590 | |
| RRVYYDEGVASSDDD | 561 | Q5JWF2 | |
| RVLYDYEAADSSELA | 341 | Q9NR46 | |
| YERKAEEEVAAAYAD | 586 | Q9NWF9 | |
| ELFEDIVAREYYSEA | 96 | Q9UQM7 | |
| RLDYSYDDFLDTVQE | 876 | Q4LDE5 | |
| YYRDSTAEEADELDG | 1821 | Q9H2D6 | |
| YSRRSYSRFEEEDDD | 41 | Q7L0J3 | |
| YFRRELDRYSLDSED | 951 | Q9UPX8 | |
| LDRYSLDSEDLYSRN | 956 | Q9UPX8 | |
| AAACERERSDEEYYA | 86 | P61812 | |
| GLSEEDDSLVDVYYR | 1491 | Q14690 | |
| AQYDYDRDDVGDRCD | 761 | P07996 | |
| LEDSYDYDDRLERRG | 266 | Q9HBT7 | |
| LSDRFRYSEDDVATY | 3051 | Q15772 | |
| RDAYADRVFDCIEVY | 476 | Q8N2H3 | |
| VYRDEAHYRDEENLE | 1516 | Q8NI35 | |
| EISLRDVEVYGFDYD | 61 | Q9H857 | |
| YLDDVYENAVDAARL | 616 | Q2M389 | |
| YETIEAYEDDLYRDE | 6 | Q8N3Z6 | |
| AYEDDLYRDESSSEL | 11 | Q8N3Z6 | |
| EVYFEDEDRAELYRV | 326 | O95801 | |
| EVDYRSDRREDYYDI | 336 | Q93009 | |
| EELEENYTRAYSEAL | 211 | P11498 | |
| DFGLARDILDREYYS | 1226 | Q04912 | |
| LRDDDFYAYDEDGTR | 146 | Q9HCX4 | |
| SDSASYAEADDERLY | 391 | O15069 | |
| TYSNEDYDRRNEDVD | 461 | Q96SB3 |